D. Weisdorf

发表

Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival.

J Wagner, J. Wagner, C. Eide, 2002, Blood.

Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation.

M. Horowitz, P. Armand, R. Soiffer, 2014, Blood.

Burden of morbidity in 10+ year survivors of hematopoietic cell transplantation: report from the bone marrow transplantation survivor study.

S. Bhatia, D. Weisdorf, J. Kersey, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study.

A. Nademanee, L. Robison, S. Bhatia, 2007, Blood.

Gene-Level Analysis of Anthracycline-Induced Cardiomyopathy in Cancer Survivors

G. Armstrong, M. Hudson, L. Robison, 2023, JACC: CardioOncology.

Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia.

J. Klein, M. Horowitz, R. Gale, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Relationship of tacrolimus (FK506) whole blood concentrations and efficacy and safety after HLA-identical sibling bone marrow transplantation.

R A Nash, J. Fay, J. Wingard, 1998, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Autologous versus unrelated donor allogeneic marrow transplantation for acute lymphoblastic leukemia.

S. Sallan, J. Ritz, M. Steinbuch, 1997, Blood.

Response to thalidomide therapy in refractory chronic graft-versus-host disease

J. Wagner, S. Davies, D. Weisdorf, 2000, Bone Marrow Transplantation.

ADVANCES IN HEMATOPOIETIC CELL TRANSPLANTATION Acute graft-versus-host disease: a bench-to-bedside update

M. Pasquini, S. Holtan, D. Weisdorf, 2014 .

Chronic graft-versus-host disease: where is promise for the future?

D. Weisdorf, D. Weisdorf, 2005, Leukemia.

Simultaneous upper and lower endoscopic biopsy in the diagnosis of intestinal graft-versus-host disease.

D. Snover, D. Weisdorf, S. Weisdorf, 1991, Transplantation.

Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age.

C Anasetti, S. Davies, C. Kollman, 2001, Blood.

Introduction to the reports from the National Cancer Institute First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.

N. Kröger, D. Porter, C. June, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Peritransplant palifermin use and lymphocyte recovery after T‐cell replete, matched related allogeneic hematopoietic cell transplantation

D. Weisdorf, B. Blazar, M. Verneris, 2011, American journal of hematology.

Autologous stem cell transplantation in multiple myeloma patients <60 vs ⩾60 years of age

S. Jagannath, R. Kyle, J. Wingard, 2003, Bone Marrow Transplantation.

Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells.

M. Farrar, D. Weisdorf, B. Blazar, 2010, Blood.

Predictive factors for chronic graft-versus-host disease after histocompatible sibling donor bone marrow transplantation.

D. Weisdorf, B. Blazar, J. Kersey, 1994, Bone marrow transplantation.

Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: an analysis of clinical risk features and outcome.

D. Weisdorf, B. Blazar, J. Kersey, 1990, Blood.

Peripheral Blood versus Bone Marrow from Unrelated Donors: Bone Marrow allografts have improved Long-term Overall and Graft-versus-Host Disease, Relapse-Free Survival Biol Blood Marrow Transplant.

J. Kanda, J. Pidala, M. Boyiadzis, 2019 .

Delayed platelet recovery after allogeneic transplantation: a predictor of increased treatment-related mortality and poorer survival

C. Brunstein, D. Weisdorf, C. Brunstein, 2011, Bone Marrow Transplantation.

The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Therapy of Multiple Myeloma : An Evidenced-Based Review

R. Kyle, J. Wingard, P. McCarthy, 2022 .

Autologous bone marrow transplantation for patients with acute lymphoblastic leukemia in second or subsequent remission: results of bone marrow treated with monoclonal antibodies BA-1, BA-2, and BA-3 plus complement.

T. Lebien, J. Kersey, D. Hurd, 1985, Blood.

National Cancer Institute's First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: summary and recommendations from the organizing committee.

N. Kröger, D. Porter, C. June, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Risky health behaviors and subsequent late mortality after blood or marrow transplantation: a BMTSS report

S. Shrestha, K. Bruxvoort, W. Landier, 2023, Blood advances.

Pretransplantation burden of leukemic progenitor cells as a predictor of relapse after bone marrow transplantation for acute lymphoblastic leukemia.

F. Uckun, D. Weisdorf, J. Kersey, 1993, The New England journal of medicine.

No Job Name

D. Sumstad, D. Kadidlo, J. McCullough, 2007 .

Acute Myeloid Leukemia

J. Rubnitz, B. Gibson, F. Smith, 2019, The New England journal of medicine.

Myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia: analysis of graft sources and long-term outcome.

D. Kaufman, J. Wagner, K. Dusenbery, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Acute graft-versus-host disease following unrelated donor marrow transplantation: failure of conventional therapy.

D. Weisdorf, B. Blazar, J. Kersey, 1992, Bone marrow transplantation.